Results 41 to 50 of about 2,007,940 (182)

Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial. [PDF]

open access: yesLancet HIV
Summary Background: Pregnant women are at 4-times higher risk of HIV per coital act than non-pregnant women. MTN-042/DELIVER was a phase 3b randomised study of the dapivirine vaginal ring (DVR) and oral tenofovir disoproxil fumarate/emtricitabine (TDF ...
Mhlanga FG   +17 more
europepmc   +2 more sources

Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis

open access: yesBMJ Open
Objectives We assessed associations between intravaginal practices (IVPs) and the incidence of sexually transmitted infections (STIs) and bacterial vaginosis (BV) among women using the dapivirine vaginal ring (DVR) or placebo vaginal ring in southwestern
Andrew Abaasa   +4 more
doaj   +2 more sources

Oral pre-exposure prophylaxis implementation in South Africa: a case study of USAID-supported programs [PDF]

open access: yesFrontiers in Reproductive Health
Since the introduction of oral pre-exposure prophylaxis (PrEP) in 2016, countries have successfully scaled-up PrEP to populations at risk of HIV acquisition, including key populations, serodiscordant couples and pregnant women.
Jerome Wendoh Milimu   +10 more
doaj   +2 more sources

PrEP preferences and early acceptability of injectable cabotegravir among pregnant and lactating people in Cape Town, South Africa: findings from the PrEPared to Choose study. [PDF]

open access: yesJ Int AIDS Soc
Abstract Introduction Providing pregnant and lactating people (PLP) with choice in HIV pre‐exposure prophylaxis (PrEP) methods, including long‐acting injectable cabotegravir (CAB‐LA), may mitigate barriers to effective PrEP use. We evaluated PrEP preferences and acceptability among PLP offered CAB‐LA versus oral PrEP in South Africa.
Wara N   +10 more
europepmc   +2 more sources

PrEP and choice counselling – Insights into implementation [PDF]

open access: yesJournal of Public Health in Africa
Adolescent girls and young women are disproportionately affected by human immunodeficiency virus (HIV). The introduction of oral pre-exposure prophylaxis (PrEP) was a game-changer in HIV prevention.
Melanie Pleaner   +7 more
doaj   +2 more sources

The dapivirine vaginal ring from the perspective of married men in Uganda [PDF]

open access: yesAfrican Journal of AIDS Research, 2021
Background: Men play a key role in influencing uptake of women's health products, such as female condoms and vaginal microbicides used for family planning and HIV prevention.Method: We explored men's perceptions of the dapivirine vaginal ring (DVR), a vaginal microbicide, in Kalungu District, rural south-western Uganda.
Anita Kabarambi   +6 more
openaire   +3 more sources

In vitro drug release, mechanical performance and stability testing of a custom silicone elastomer vaginal ring releasing dapivirine and levonorgestrel

open access: yesInternational Journal of Pharmaceutics: X, 2022
We have previously reported a multipurpose silicone elastomer vaginal ring providing sustained release of dapivirine (an antiretroviral) and levonorgestrel (a progestin) for HIV prevention and hormonal contraception.
Diarmaid J. Murphy   +12 more
doaj   +1 more source

Strategies implemented for accurate dispensing of an investigational new drug in a multi-site HIV prevention clinical trial

open access: yesContemporary Clinical Trials Communications, 2021
Safe practices for dispensing investigational product (IP) during clinical trials are not standardized and information in this regard is often limited.
Cindy Jacobson   +12 more
doaj   +1 more source

Promises and potential pitfalls of long-acting injectable pre-exposure prophylaxis

open access: yesSouthern African Journal of HIV Medicine, 2023
The number of products that can provide pre-exposure prophylaxis (PrEP) for HIV prevention is expanding, with three now approved in South Africa (oral Tenofovir-based PrEP, injectable Cabotegravir, and a Dapivirine-based vaginal ring) and more in the ...
Carey Pike   +2 more
doaj   +1 more source

Acceptability and use of a dapivirine vaginal ring in a phase III trial [PDF]

open access: yesAIDS, 2017
The MTN-020/ASPIRE trial evaluated the safety and effectiveness of the dapivirine vaginal ring for prevention of HIV-1 infection among African women. A nested qualitative component was conducted at six of 15 study sites in Uganda, Malawi, Zimbabwe and South Africa to evaluate acceptability of and adherence to the ring.Qualitative study participants (n =
Elizabeth T, Montgomery   +15 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy